Kommentar
In small-intestinal angiodysplasia with recurrent bleeding, thalidomide reduced bleeding episodes at 1 y
Annals of Internal Medicine · 2024
DOI: 10.7326/j24-0005 ↗Kurz gefasst
Kommentar in der Zeitschrift Annals of Internal Medicine, 2024. Verfasst von Aaron Hakim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA (A.H., J.D.F.). Hauptthemen laut MEDLINE: Thalidomide, Angiodysplasia.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
ThalidomideAngiodysplasiaHumansGastrointestinal HemorrhageRecurrence
Substanzen
Thalidomide
Autor:innen und Institutionen
- Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA (A.H., J.D.F.).
Zitieren
APA
Hakim, A., & Feuerstein, J. D. (2024). In small-intestinal angiodysplasia with recurrent bleeding, thalidomide reduced bleeding episodes at 1 y. Annals of Internal Medicine. https://doi.org/10.7326/j24-0005
Vancouver
Hakim A, Feuerstein JD. In small-intestinal angiodysplasia with recurrent bleeding, thalidomide reduced bleeding episodes at 1 y. Annals of Internal Medicine. 2024. doi:10.7326/j24-0005
BibTeX
@article{Hakim2024,
author = {Hakim, Aaron and Feuerstein, Joseph D},
title = {In small-intestinal angiodysplasia with recurrent bleeding, thalidomide reduced bleeding episodes at 1 y},
journal = {Annals of Internal Medicine},
year = {2024},
doi = {10.7326/j24-0005}
}
EUVIMED